Type 2 Bias of T cells expanded from the blood of melanoma patients switched to type 1 by IL-12p70 mRNA-transfected dendritic cells.
about
Therapeutic cancer vaccines: past, present, and futureTumour tissue microenvironment can inhibit dendritic cell maturation in colorectal cancerDendritic cell-based vaccines: barriers and opportunitiesMatrix metalloproteinase-2 conditions human dendritic cells to prime inflammatory T(H)2 cells via an IL-12- and OX40L-dependent pathwayTumor-Associated Glycans and Immune SurveillanceImmunoglobulin-like transcript receptors on human dermal CD14+ dendritic cells act as a CD8-antagonist to control cytotoxic T cell primingIL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity.RNA as performance-enhancers for dendritic cells.Directing dendritic cell immunotherapy towards successful cancer treatment.Recent developments in cancer vaccinesEngineering dendritic cells to enhance cancer immunotherapy.Dendritic cell immunotherapy in ovarian cancer.Human dendritic cells subsets as targets and vectors for therapy.Immune alterations in malignant melanoma and current immunotherapy concepts.Antigen-specific vaccines for cancer treatment.Oncolytic Newcastle Disease Virus as Cutting Edge between Tumor and HostModification of human embryonic stem cell-derived dendritic cells with mRNA for efficient antigen presentation and enhanced potency.The HSV-2 mutant DeltaPK induces melanoma oncolysis through nonredundant death programs and associated with autophagy and pyroptosis proteins.Dendritic cell inhibition correlates with survival of colorectal cancer patients on bevacizumab treatment.Dendritic cell immunotherapy.Dendritic cells: active and passive players in therapy of human diseases.Lipid Accumulation in Peripheral Blood Dendritic Cells and Anticancer Immunity in Patients with Lung Cancer.
P2860
Q26863283-4E4A07BE-3776-4EE8-AB42-B30DD2331752Q34085831-08E63317-4CAE-4BD7-A6AD-237B924B8EA8Q34661797-65B5A0A2-330F-42AC-A889-DC34449B2844Q34778175-CD2346A2-DF59-478B-BBD1-0D10F3FEF25FQ35890610-27ECB3DD-4000-475D-9FB6-6C2DD62C7BBFQ36414778-CDB335D7-6B59-4F2F-AA93-0E15CBD11312Q37052943-3AA6E849-B5DA-44F2-A48A-0FE5EB878D63Q37686532-8BD7FBB1-3CB5-43AB-93DD-6E39DD2501FDQ37754014-B399465D-522F-47A7-AE90-0C3283041BE2Q37830226-D5391CDB-B391-4EED-A21A-7465B8CBE88AQ37862064-FDACA5F8-20D8-4C3B-8FF9-4AED4013679AQ38069183-8B601846-83DE-46AF-AE49-F99C3B136A18Q38104772-D6511210-6ADC-42BB-870C-8E0F85954628Q38127733-A7458936-A007-470B-92EF-4F146D3AC0C0Q38284692-EED5941B-EDAE-498B-9582-E4EDBFE99BA0Q38369289-CE2324F1-2D7C-4B28-82B6-A0F2A91DE0B5Q39547016-8270FEC9-1C33-4B40-955E-B4517B1182CEQ39792514-ED9C4ED9-0485-4F0C-AF36-FDA444A96CC3Q42403366-4ACE73D1-8565-44EF-8360-77BDF9F94401Q44483910-CE482B52-22D4-4299-9807-7DFF82CF293FQ48356067-D0EC88A9-2AE3-4FE0-9DD3-89FB768B4D7EQ55292718-4F4CF679-21D5-4EAA-B3AD-FF12A85AB9D9
P2860
Type 2 Bias of T cells expanded from the blood of melanoma patients switched to type 1 by IL-12p70 mRNA-transfected dendritic cells.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Type 2 Bias of T cells expande ...... A-transfected dendritic cells.
@en
Type 2 Bias of T cells expande ...... A-transfected dendritic cells.
@nl
type
label
Type 2 Bias of T cells expande ...... A-transfected dendritic cells.
@en
Type 2 Bias of T cells expande ...... A-transfected dendritic cells.
@nl
prefLabel
Type 2 Bias of T cells expande ...... A-transfected dendritic cells.
@en
Type 2 Bias of T cells expande ...... A-transfected dendritic cells.
@nl
P2093
P2860
P50
P1433
P1476
Type 2 Bias of T cells expande ...... A-transfected dendritic cells.
@en
P2093
Anna Pavlick
Daniel G Kavanagh
David O'Neill
Dusan Bogunovic
Galit Alter
Kira Minkis
Nina Bhardwaj
Rajesh T Gandhi
P2860
P304
P356
10.1158/0008-5472.CAN-08-0900
P407
P577
2008-11-01T00:00:00Z